Aspiration Therapy As a Tool to Treat Obesity: 1- to 4-Year Results in a 201-Patient Multi-Center Post-Market European Registry Study
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The objective of this post-market study was to evaluate long-term safety and efficacy of aspiration therapy (AT) in a clinical setting in five European clinics. The AspireAssist® System (Aspire Bariatrics, Inc. King of Prussia, PA) is an endoscopic weight loss therapy utilizing a customized percutaneous endoscopic gastrostomy tube and an external device to aspirate approximately 30% of ingested calories after a meal, in conjunction with lifestyle counseling. A total of 201 participants, with body mass index (BMI) of 35.0–70.0 kg/m 2 , were enrolled in this study from June 2012 to December 2016. Mean baseline BMI was 43.6 ± 7.2 kg/m 2 . Mean percent total weight loss at 1, 2, 3, and 4 years, respectively, was 18.2% ± 9.4% ( n / N = 155/173), 19.8% ± 11.3% ( n / N = 82/114), 21.3% ± 9.6% ( n / N = 24/43), and 19.2% ± 13.1% ( n / N = 12/30), where n is the number of measured participants and N is the number of participants in the absence of withdrawals or lost to follow-up. Clinically significant reductions in glycated hemoglobin (HbA1C), triglycerides, and blood pressure were observed. For participants with diabetes, HbA1C decreased by 1% ( P < 0.0001) from 7.8% at baseline to 6.8% at 1 year. The only serious complications were buried bumpers, experienced by seven participants and resolved by removal/replacement of the A-Tube, and a single case of peritonitis, resolved with a 2-day course of intravenous antibiotics. This study establishes that aspiration therapy is a safe, effective, and durable weight loss therapy in people with classes II and III obesity in a clinical setting. ISRCTN 49958132
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“However, 59% of participants treated with these hydrogel capsules achieved non-eplacebo-subtracted weight loss ≥5%, and persons with prediabetes or drug-naïve T2D were more likely to achieve a favorable weight-loss response.786”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [786]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Some endoscopic and orally delivered devices have been approved by the FDA for treatment of obesity, including hydrogel capsules,786 intragastric balloon systems,787–788 a transpyloric shuttle that blocks gastric emptying,789 and gastric aspiration therapy that evacuates partial gastric contents following meals via a variation of a percutaneous endoscopic gastrostomy tube.790”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [786]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The hydrogel capsules are well tolerated and in the Gelesis Loss of Weight (GLOW) study produced 2% placebo-subtracted weight loss.786”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [786]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Hibbard, J. H., & Greene, J. (2013) · Health Affairs · doi:10.1377/hlthaff.2012.1061 · Cited by 1,787 · cited 1×
“Medicine today is trending towards patients becoming more active participants in the management of their healthcare [25].”
BackgroundMetabolic/Bariatric Surgery Worldwide 2011
Buchwald, H., & Oien, D. M. (2013) · Obesity Surgery · doi:10.1007/s11695-012-0864-0 · Cited by 1,694
Trends and Correlates of Class 3 Obesity in the United States From 1990 Through 2000
Freedman, D. S. (2002) · JAMA · doi:10.1001/jama.288.14.1758 · Cited by 458
Percutaneous endoscopic gastrostomy: a nonoperative technique for feeding gastrostomy
Ponsky, J. L., & Gauderer, M. W. L. (1981) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(81)73133-x · Cited by 445
Kitahara, C. M., Flint, A. J., Berrington de Gonzalez, A., Bernstein, L., Brotzman, M., MacInnis, R. J., Moore, S. C., Robien, K., Rosenberg, P. S., Singh, P. N., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001673 · Cited by 433
(2007) · PubMed · Cited by 390
AGA technical review on obesity
Klein, S., Wadden, T., & Sugerman, H. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35514 · Cited by 274
Grant, D. G., Bradley, P. T., Pothier, D. D., Bailey, D., Caldera, S., Baldwin, D. L., & Birchall, M. A. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01889.x · Cited by 227
Percutaneous endoscopic gastrostomy: A review of indications, complications and outcome
Nicholson, F. B., Korman, M. G., & Richardson, M. A. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02004.x · Cited by 215 · cited 1×
“Apart from the A-Tube rotation (the internal end rotating from the fundus towards the pylorus), all other complications reported in this study are similar (or less) in type, severity, and frequency as those reported in the literature with PEG tubes [22].”
Result
Cited by
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
Ruze, R., Liu, T., Zou, X., Song, J., Chen, Y., Xu, R., Yin, X., & Xu, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1161521 · Cited by 799
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Recent advances in bariatric surgery: a narrative review of weight loss procedures
Aderinto, N., Olatunji, G. D., Kokori, E., Olaniyi, P., Isarinade, D. T., & Yusuf, I. A. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001472 · Cited by 148
“However, some participants discontinued the therapy for various reasons, necessitating further research to understand its bene fi ts and drawbacks [48] .”
BackgroundJirapinyo, P., Hadefi, A., Huberty, V., Sullivan, S. A., Thompson, C. C., Patai, Á. V., Pannala, R., Goelder, S. K., Kushnir, V. M., Barthet, M. A., et al. (2024) · Endoscopy · doi:10.1055/a-2292-2494 · Cited by 77
“For the subgroup with class III obesity, 20 observational studies (n=2776) informed the outcomes of percentage of TWL at 6 to 12 months [48,50 – 52,55 – 57,59,61,65 – 69,71 – 75,81] and 10 studies (n=815) for HbA1c reduction at 12 months [50,51,58,59,79 – 84].”
Influential
Metadata
- Authors
- Nyström, M., Machytka, E., Norén, E., Testoni, P. A., Janssen, I., Turró Homedes, J., Espinos Perez, J. C., & Turro Arau, R.
- Affiliations
- Region Blekinge (SE)
- IRCCS Ospedale San Raffaele (IT)
- Corresponding author
- Nyström, Max
- Venue
- Obesity Surgery
- Published
- 2018-02-01
- Volume
- 28
- Issue
- 7
- Pages
- 1860-1868
- ISSN
- 0960-8923 (ISSN-L)
- 1708-0428
- PMC
- PMC6018576
- OpenAlex
- W2786356431
- Cited by
- 73
- References
- 26
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 8 · 2022: 10 · 2021: 10 · 2020: 17 · 2019: 13 · 2018: 4
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Obesity Surgery (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Scientific Commitee of Blekinge County Council Sweden
- Mina Medical AB Sweden
- Slanka Sweden AB
- Aspire Bariatrics, Inc.
- Scientific Committee of Blekinge County Council, Sweden
- Mina Medical AB, Sweden
- Slanka Sweden AB, Sweden
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Body Contouring and Surgery
- Keywords
- aspiration therapy
- MeSH terms
- Adult, Aged, Blood Pressure, Diabetes Mellitus, Europe, Female, Gastrostomy, Glycated Hemoglobin, Humans, Life Style, Male, Middle Aged, Obesity, Obesity, Morbid, Registries, Suction, Weight Loss, Body Mass Index, Bariatrics, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aspiration Therapy As a Tool to Treat Obesity: 1- to 4-Year Results in a 201-Patient Multi-Center Post-Market European Registry Study. https://app.cochat.ai/papers/10.1007/s11695-017-3096-5
- The paper
- Nyström, M., Machytka, E., Norén, E., Testoni, P. A., Janssen, I., Turró Homedes, J., Espinos Perez, J. C., & Turro Arau, R. (2018). Aspiration Therapy As a Tool to Treat Obesity: 1- to 4-Year Results in a 201-Patient Multi-Center Post-Market European Registry Study. Obesity Surgery. https://doi.org/10.1007/s11695-017-3096-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

